Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR

MISIIR is a potential target for ovarian cancer (OC) therapy due to its tissue-specific pattern of expression. 3C23K is a novel therapeutic monoclonal anti-MISIIR antibody designed to recruit effector cells and promote cell death through ADCC (antibody dependent cell-mediated cytotoxicity). Our obje...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Sarah E., Zhang, Qing, Keeney, Gary L., Cliby, William A., Weroha, S. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689604/
https://www.ncbi.nlm.nih.gov/pubmed/29156714
http://dx.doi.org/10.18632/oncotarget.19620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689604/
https://www.ncbi.nlm.nih.gov/pubmed/29156714
http://dx.doi.org/10.18632/oncotarget.19620

Ejemplares similares